Dr. Fabian Falkenbach (@ffmed) 's Twitter Profile
Dr. Fabian Falkenbach

@ffmed

Urologist @MartiniKlinik , Research Fellow @crchum

ID: 103137138

calendar_today09-01-2010 01:07:45

2,2K Tweet

452 Followers

2,2K Following

Adam B. Weiner, MD (@adam_weiner535) 's Twitter Profile Photo

🚨Aiming High: PSMA Expression in Treatment-naïve #prostatecancer 👏Martin Bakht & Misha Beltran provide editorial comments on our latest publication in European Urology "Given that PSMA PET scans are now routinely performed in newly diagnosed patients, this study is increasingly

🚨Aiming High: PSMA Expression in Treatment-naïve #prostatecancer 

👏<a href="/mkbakht/">Martin Bakht</a> &amp; <a href="/mishabeltran/">Misha Beltran</a> provide editorial comments on our latest publication in <a href="/EUplatinum/">European Urology</a> 

"Given that PSMA PET scans are now routinely performed in newly diagnosed patients, this study is increasingly
NEJM (@nejm) 's Twitter Profile Photo

A randomized trial showed noninferiority of stereotactic body radiotherapy to conventionally or moderately hypofractionated radiotherapy in preventing biochemical recurrence in selected men with localized prostate cancer. Full PACE-B trial results: nej.md/3Y7coBm

A randomized trial showed noninferiority of stereotactic body radiotherapy to conventionally or moderately hypofractionated radiotherapy in preventing biochemical recurrence in selected men with localized prostate cancer. Full PACE-B trial results: nej.md/3Y7coBm
European Urology (@euplatinum) 's Twitter Profile Photo

Cutting Edge Communication: Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials by Daniel E Spratt et al Read the full article here:

Cutting Edge Communication: Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials by <a href="/DrSpratticus/">Daniel E Spratt</a> et al 

Read the full article here:
UroToday.com (@urotoday) 's Twitter Profile Photo

Exciting developments in PSMA-targeted therapies for #ProstateCancer! This review explores the challenges of PSMA heterogeneity and the potential of combination therapies to enhance treatment outcomes. #ReadNow on UroToday > bit.ly/3AFgdWd Misha Beltran Jean-Philippe Theurillat

Exciting developments in PSMA-targeted therapies for #ProstateCancer! This review explores the challenges of PSMA heterogeneity and the potential of combination therapies to enhance treatment outcomes. 
#ReadNow on UroToday &gt; bit.ly/3AFgdWd <a href="/mishabeltran/">Misha Beltran</a> <a href="/JTheurillat/">Jean-Philippe Theurillat</a>
Enrico Checcucci (@enricocheccucci) 's Twitter Profile Photo

♊️ #DigitalTwins are paving the way for customized surgical planning and oncological pathways in #urology. Daniele Amparore pas_rescigno European Urology Oncology 👀 Is this already becoming a reality?" 👉 kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

♊️ #DigitalTwins are paving the way for customized surgical planning and oncological pathways in #urology. <a href="/danieleamparore/">Daniele Amparore</a> <a href="/PasRescigno/">pas_rescigno</a> <a href="/EurUrolOncol/">European Urology Oncology</a> 

👀 Is this already becoming a reality?"

👉 kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Most viewed in the last 7 days from JAMA Oncology: Is diet associated with risk of prostate cancer grade reclassification in men diagnosed with grade group 1 disease undergoing active surveillance? ja.ma/4fl1XB1

Most viewed in the last 7 days from <a href="/JAMAOnc/">JAMA Oncology</a>: 

Is diet associated with risk of prostate cancer grade reclassification in men diagnosed with grade group 1 disease undergoing active surveillance? 

ja.ma/4fl1XB1
Veeru Kasi (@veerukasi) 's Twitter Profile Photo

🚨MicroUS 🚨#OPTIMUM RCT for prostate cancer detection - 👏🏾 for completing trial. Eagerly awaiting results Hannes Cash leaving us in suspense - need to wait for #EAU25. Was hoping for 🎅to come early 😉 #EMUC24 European Association of Urology (EAU) European Society of Residents in Urology

🚨MicroUS 🚨#OPTIMUM RCT for prostate cancer detection -  👏🏾 for completing trial. Eagerly awaiting results <a href="/CashHannes/">Hannes Cash</a> leaving us in suspense - need to wait for #EAU25. Was hoping for 🎅to come early 😉 #EMUC24 <a href="/Uroweb/">European Association of Urology (EAU)</a> <a href="/ESRUrology/">European Society of Residents in Urology</a>
Baris Turkbey MD (@radiolobt) 's Twitter Profile Photo

Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and mpMRI jnm.snmjournals.org/content/early/… 👍Very important publication from UCLA group, congratulations🎉 #ProstateCancer #MolecularImaging #CancerResearch

Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and mpMRI jnm.snmjournals.org/content/early/…
👍Very important publication from UCLA group, congratulations🎉
#ProstateCancer #MolecularImaging #CancerResearch
Adam B. Weiner, MD (@adam_weiner535) 's Twitter Profile Photo

🚨Overtreatment of #ProstateCancer Among Men With Limited Longevity🚨 👉Just out in JAMA Internal Medicine 🧑🧔‍♂️👴>240k pts w/ localized PCa from the VA (2000-2019) 📈Increased use of surveillance for low-risk tumors😃 BUT ALSO 📈Increased definitive treatment (surgery or XRT) for

🚨Overtreatment of #ProstateCancer  Among Men With Limited Longevity🚨

👉Just out in <a href="/JAMAInternalMed/">JAMA Internal Medicine</a> 

🧑🧔‍♂️👴&gt;240k pts w/ localized PCa from the VA (2000-2019)

📈Increased use of surveillance for low-risk tumors😃
BUT ALSO
📈Increased definitive treatment (surgery or XRT) for
Dr. Fabian Falkenbach (@ffmed) 's Twitter Profile Photo

💥 Just published💥 Wondering how PSMA imaging and genetics will influence focal therapy for prostate cancer in the future? This book chapter discusses how modern patient selection for focal therapy can improve cancer control outcomes. link.springer.com/chapter/10.100…

💥 Just published💥
Wondering how PSMA imaging and genetics will influence focal therapy for prostate cancer in the future? This book chapter discusses how modern patient selection for focal therapy can improve cancer control outcomes. link.springer.com/chapter/10.100…
Dr. Fabian Falkenbach (@ffmed) 's Twitter Profile Photo

Like Twitter in the good old days, but more powerful with customized feed, starter packs, less bs - join bluesky bsky.app/profile/ffmed.…

Yüksel Ürün (@dryukselurun) 's Twitter Profile Photo

Conventional imaging understages high-risk nonmetastatic prostate cancer. ☢️PSMA-PET was positive in 84% of cases, detecting M1 disease in 46%, polymetastatic in 24%. #ProstateCancer #PSMAPET #Oncology OncoAlert JAMA Network Open Advanced Prostate Cancer Consensus Conference

Conventional imaging understages high-risk nonmetastatic prostate cancer. 
☢️PSMA-PET was positive in 84% of cases, detecting M1 disease in 46%, polymetastatic in 24%. 
#ProstateCancer #PSMAPET #Oncology <a href="/OncoAlert/">OncoAlert</a> <a href="/JAMANetworkOpen/">JAMA Network Open</a> <a href="/APCCC_Lugano/">Advanced Prostate Cancer Consensus Conference</a>
European Urology Oncology (@eururoloncol) 's Twitter Profile Photo

Patient Preference of Apalutamide Versus Enzalutamide for Recurrent or Metastatic Hormone-sensitive Prostate Cancer: An Open-label, Randomized, Crossover Trial by Chi-Fai Ng et al buff.ly/4gsUFfe #UroSoMe #MedTwitter #EUO #PCa #ProstateCancer

Patient Preference of Apalutamide Versus Enzalutamide for Recurrent or Metastatic Hormone-sensitive Prostate Cancer: An Open-label, Randomized, Crossover Trial by Chi-Fai Ng et al

buff.ly/4gsUFfe 

#UroSoMe #MedTwitter #EUO #PCa #ProstateCancer
Michael Hofman (@drmhofman) 's Twitter Profile Photo

Impact of intraprostatic PSMA SUVmax following prostatectomy: a systematic review and meta-analysis First publication of 2025 - congrats David Chen marlon perera BJU International doi.org/10.1111/bju.16… "Preoperative intraprostatic PSMA SUVmax increases monotonically with higher ISUP

Impact of intraprostatic PSMA SUVmax following prostatectomy: a systematic review and meta-analysis

First publication of 2025 - congrats <a href="/davcmed/">David Chen</a> <a href="/drMPerera/">marlon perera</a> 

<a href="/BJUIjournal/">BJU International</a> 
doi.org/10.1111/bju.16…

"Preoperative intraprostatic PSMA SUVmax increases monotonically with higher ISUP
Prost8UK (@prost8uk) 's Twitter Profile Photo

Catching prostate cancer early can open the door to less invasive treatments like HIFU, Cryotherapy and NanoKnife. Early detection gives you the power to choose the path that’s right for you—without compromising your quality of life. 🩺 Over 50? Talk to your doctor today.

Catching prostate cancer early can open the door to less invasive treatments like HIFU, Cryotherapy and NanoKnife. Early detection gives you the power to choose the path that’s right for you—without compromising your quality of life.

🩺 Over 50? Talk to your doctor today.
Dr. Fabian Falkenbach (@ffmed) 's Twitter Profile Photo

And even if you need a RP later - no problem: quality of life was not more affected than after primary RP, decision regret was low mdpi.com/2072-6694/17/3…

European Urology Open Science (@eururolopen) 's Twitter Profile Photo

PCa: Patient-reported Outcome Measures and Decision Regret After Prostate-specific Membrane Antigen–targeted Radioguided Surgery for Oligorecurrent Prostate Cancer by Dr. Fabian Falkenbach et al Full article: buff.ly/3EqnUS0 #UroSoMe #MedTwitter #PCa #ProstateCancer #euros

PCa: Patient-reported Outcome Measures and Decision Regret After Prostate-specific Membrane Antigen–targeted Radioguided Surgery for Oligorecurrent Prostate Cancer by <a href="/ffmed/">Dr. Fabian Falkenbach</a> et al

Full article: buff.ly/3EqnUS0 

#UroSoMe #MedTwitter #PCa #ProstateCancer #euros
Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

Ab#22 ASCO #GU25 by Dr. Tamim Niazi👉bit.ly/4hMu4KE👉Randomized ph2 study of MDT in oligometastatic CRPC #prostatecancer👉addition of SBRT to SOC doubled the median rPFS (& delayed time to next Rx)👇#ScottTyldesley OncoAlert UroToday.com PCF Science

Ab#22 <a href="/ASCO/">ASCO</a> #GU25 by <a href="/niazi_Dr7/">Dr. Tamim Niazi</a>👉bit.ly/4hMu4KE👉Randomized ph2 study of MDT in oligometastatic CRPC #prostatecancer👉addition of SBRT to SOC doubled the median rPFS (&amp; delayed time to next Rx)👇#ScottTyldesley <a href="/OncoAlert/">OncoAlert</a> <a href="/urotoday/">UroToday.com</a> <a href="/PCF_Science/">PCF Science</a>